Cong Lin

3.3k total citations
63 papers, 1.5k citations indexed

About

Cong Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Cong Lin has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Pharmacology. Recurrent topics in Cong Lin's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Cannabis and Cannabinoid Research (6 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Cong Lin is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Cannabis and Cannabinoid Research (6 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Cong Lin collaborates with scholars based in China, United States and France. Cong Lin's co-authors include Schahram Akbarian, Frederick A. Schroeder, Wim E. Crusio, Marcia Meseck, H. Henry Dong, Jennifer Altomonte, Anja Richter, Jing Xu, Sonal Harbaran and C. Arnold Spek and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Cong Lin

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cong Lin China 17 693 237 195 191 157 63 1.5k
Jing Wu China 30 1.1k 1.7× 215 0.9× 97 0.5× 125 0.7× 227 1.4× 98 2.3k
Xu Cheng China 21 599 0.9× 127 0.5× 103 0.5× 107 0.6× 306 1.9× 66 1.5k
I‐Chen Yu United States 19 580 0.8× 192 0.8× 286 1.5× 108 0.6× 193 1.2× 36 1.4k
Lihua Chen China 20 587 0.8× 276 1.2× 277 1.4× 386 2.0× 110 0.7× 68 1.4k
Guang Chen China 23 955 1.4× 130 0.5× 107 0.5× 106 0.6× 145 0.9× 86 2.0k
Martina Chiappelli Italy 23 519 0.7× 523 2.2× 80 0.4× 108 0.6× 247 1.6× 43 1.6k
Qiong Yu China 21 1.0k 1.5× 87 0.4× 86 0.4× 108 0.6× 97 0.6× 160 1.9k
Giacomo Pozzoli Italy 22 575 0.8× 219 0.9× 242 1.2× 98 0.5× 75 0.5× 57 1.9k
Michael P. O’Donnell United States 21 795 1.1× 157 0.7× 275 1.4× 542 2.8× 110 0.7× 46 2.5k
Maria Grazia Cattaneo Italy 26 827 1.2× 165 0.7× 239 1.2× 149 0.8× 257 1.6× 72 1.9k

Countries citing papers authored by Cong Lin

Since Specialization
Citations

This map shows the geographic impact of Cong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Lin more than expected).

Fields of papers citing papers by Cong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Lin. The network helps show where Cong Lin may publish in the future.

Co-authorship network of co-authors of Cong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Cong Lin. A scholar is included among the top collaborators of Cong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cong Lin. Cong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Cong, et al.. (2025). Radioprotection redefined: drug discovery at the intersection of tardigrade biology and translational pharmacology. Frontiers in Pharmacology. 16. 1713914–1713914.
2.
Wang, Xue, Xin Zhou, Pu Jiang, et al.. (2025). Chiral recognition of CIAC001 isomers in regulating pyruvate kinase M2 and mitigating neuroinflammation. European Journal of Medicinal Chemistry. 285. 117262–117262. 3 indexed citations
3.
Lin, Cong, et al.. (2025). Nanomolar TLR4 Antagonist CIAC101 Derived from (+)-Naltrexone Blocks Microglial Activation and Methamphetamine Addiction. Journal of Medicinal Chemistry. 68(23). 25469–25484. 1 indexed citations
5.
Lin, Cong, Xiaoxuan Zhou, Mingqi Li, et al.. (2025). S‐ketamine Alleviates Neuroinflammation and Attenuates Lipopolysaccharide‐Induced Depression Via Targeting SIRT2. Advanced Science. 12(23). e2416481–e2416481. 4 indexed citations
6.
Lin, Cong, et al.. (2025). GlycoRNA: a new frontier in RNA biology. Science China Life Sciences. 69(1). 293–296. 1 indexed citations
7.
9.
Lin, Cong, Yibo Wang, Hongshuang Wang, et al.. (2023). Cannabidiol Analogue CIAC001 for the Treatment of Morphine-Induced Addiction by Targeting PKM2. Journal of Medicinal Chemistry. 66(16). 11498–11516. 15 indexed citations
10.
Li, Fei, Ting Luo, Luís Nunes, et al.. (2023). 572P Neoantigen heterogeneity among subtypes in colorectal cancer. Annals of Oncology. 34. S421–S421. 1 indexed citations
11.
Yu, Hang, Bao‐Ying Wen, Min Huang, et al.. (2023). TCP-1, a novel peptide to diagnose early colon cancer. Chinese Chemical Letters. 35(3). 108235–108235.
12.
Luo, Huijuan, Tian Luo, Nannan Li, et al.. (2023). The performance of whole genome bisulfite sequencing on DNBSEQ-Tx platform examined by different library preparation strategies. Heliyon. 9(6). e16571–e16571. 11 indexed citations
13.
Chu, Chen, Hengcai Zhang, Jiayin Zhang, Cong Lin, & Feng Lu. (2023). Assessing impacts of the Russia-Ukraine conflict on global air transportation: From the view of mass flight trajectories. Journal of Air Transport Management. 115. 102522–102522. 17 indexed citations
14.
Liu, Jinxin, Xialan Zhang, Wen Su, et al.. (2022). Insights into the fates of plasmids and antimicrobial resistance genes during swine manure treatment and related factors based on plasmidome and metagenome analyses. Environmental Science and Pollution Research. 29(45). 69037–69047. 4 indexed citations
15.
Wang, Xue, Cong Lin, Tianshu Zhang, et al.. (2022). Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia. Frontiers in Immunology. 13. 929222–929222. 13 indexed citations
16.
Zhang, Tianshu, et al.. (2022). ACT001 Inhibits TLR4 Signaling by Targeting Co-Receptor MD2 and Attenuates Neuropathic Pain. Frontiers in Immunology. 13. 873054–873054. 14 indexed citations
17.
Li, Nannan, Han Liang, Cong Lin, et al.. (2022). Detecting and monitoring bladder cancer with exfoliated cells in urine. Frontiers in Oncology. 12. 986692–986692. 1 indexed citations
18.
Li, Xiaojiao, Tong Zhang, Qianli Ma, et al.. (2022). Effect of visceral adipose tissue on the accuracy of preoperative T-staging of gastric cancer. European Journal of Radiology. 155. 110488–110488. 6 indexed citations
19.
Zhang, Hongyu, Fangyan Chen, Xu Fan, et al.. (2017). Quantitative Proteomic analysis on Activated Hepatic Stellate Cells reversion Reveal STAT1 as a key regulator between Liver Fibrosis and recovery. Scientific Reports. 7(1). 44910–44910. 26 indexed citations
20.
Lin, Cong, Jan H. von der Thüsen, Joost Daalhuisen, et al.. (2015). Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis. Molecular Medicine. 21(1). 576–583. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026